Projects funded by the NCN

Mechanistic insight in Transmembrane Protein (TMEM) deregulation and its contribution to ccRCC etiology

Call: OPUS 8 , Panel: NZ2

Principal investigator: dr hab. Joanna Wesoły

Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii

Identification of new markers of clear cell carcinoma stem cells - in vivo mouse study employing molecular imaging

Call: OPUS 7 , Panel: NZ1

Principal investigator: prof. Cezary Szczylik

Wojskowy Instytut Medyczny

An investigation of Endocannabinoid System (ECS) on Cancer Initiating Cells (CICs) in Renal Cell Carcinoma (RCC)

Call: PRELUDIUM 5 , Panel: NZ5

Principal investigator: Mohammed Khan

Wojskowy Instytut Medyczny

Molecular analysis of clear cell renal cell carcinoma progression in the context of the search for predictive factors pr...

Call: SONATA 5 , Panel: NZ5

Principal investigator: dr Katarzyna Miękus

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Analysis of YAP1 gene function as a potential oncogene of renal cell carcinoma based on clinical material and cell lines...

Call: OPUS 3 , Panel: NZ4

Principal investigator: prof. Zbigniew Kmieć

Gdański Uniwersytet Medyczny, Wydział Lekarski

Epigenetic regulation of DDR1 and IKK beta in renal carcinoma cell lines - a role of micro-RNA-199a-5p and micro-RNA-199...

Call: OPUS 3 , Panel: NZ4

Principal investigator: dr Jolanta Kiewisz

Uniwersytet Warmińsko-Mazurski w Olsztynie, Wydział Nauk Medycznych

MicroRNA-dependent regulation of adhesion-related molecules in clear cell renal cell carcinoma: the search for markers o...

Call: OPUS 3 , Panel: NZ5

Principal investigator: dr hab. Agnieszka Piekiełko-Witkowska

Centrum Medyczne Kształcenia Podyplomowego

Transcriptome analysis within three subtypes of clear cell renal cell carcinoma cells by RNA sequencing method

Call: PRELUDIUM 3 , Panel: NZ2

Principal investigator: Tomasz Wrzesiński

Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii

Molecular and cellular mechanisms responsible for the initiation and progression of clear cell renal cell carcinoma

Call: OPUS 23 , Panel: NZ5

Principal investigator: dr hab. Katarzyna Miękus

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Analysis of molecular background of clear cell renal cell carcinoma and role of MCPIP1 in tomorigenesis

Call: OPUS 2 , Panel: NZ1

Principal investigator: prof. Jolanta Jura

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Regulatory role of miRNAs and modification of β-catenin in the metastatic potential of clear cell renal cell carcinoma.

Call: PRELUDIUM 20 , Panel: NZ5

Principal investigator: Judyta Górka

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Regulation of Serpine1 expression in kidney cancer - role of hypoxia

Call: PRELUDIUM 19 , Panel: NZ5

Principal investigator: Aleksandra Majewska

Wojskowy Instytut Medyczny

Role of Angiotensin-(1-7) in patogenesis of renal cell carcinoma

Call: PRELUDIUM 14 , Panel: NZ5

Principal investigator: Pawel Sobczuk

Warszawski Uniwersytet Medyczny, Wydział Lekarski

The role of MCPIP1 as a potential tumor suppressor during development and treatment of clear cell renal cell carcinoma

Call: PRELUDIUM 13 , Panel: NZ5

Principal investigator: dr Paulina Marona

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Metabolic profiles, epidemiologic data and advanced bioinformatic tools in a holistic approach for the classification of...

Call: PRELUDIUM 10 , Panel: NZ7

Principal investigator: dr Marta Kordalewska

Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny

The role of MCPIP1 protein in growth, progression and vascularisation of clear cell renal cell carcinoma.

Call: OPUS 10 , Panel: NZ5

Principal investigator: dr hab. Katarzyna Miękus

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Protein and gene expression analysis in the course of renal cancer stem-like cells' primary resistance to sorafenib in h...

Call: PRELUDIUM 9 , Panel: NZ5

Principal investigator: Zofia Bielecka

Wojskowy Instytut Medyczny